Special considerations in the management of patients with myelodysplastic myndrome / myeloproliferative neoplasm overlap syndromes during the SARS‐CoV‐2 pandemic

Ítems similars

• Infrequent occurrence of TET1, TET3, and ASXL2 mutations in myelodysplastic/myeloproliferative neoplasms
  per: Lasho, Terra L., et al.
  Publicat: (2018)
• Genomics of myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes
  per: Patnaik, Mrinal M., et al.
  Publicat: (2020)
• Myelodysplastic syndrome/myeloproliferative neoplasm overlap syndromes: a focused review
  per: Patnaik, Mrinal M., et al.
  Publicat: (2020)
• Sodium-glucose co-transporter-2 inhibitor treatment-associated changes in hemoglobin level in anemic patients with myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms
  per: Ali Alsugair, et al.
  Publicat: (2025-01-01)
• Biallelic inactivation of the retinoblastoma gene results in transformation of chronic myelomonocytic leukemia to a blastic plasmacytoid dendritic cell neoplasm: shared clonal origins of two aggressive neoplasms
  per: Patnaik, Mrinal M., et al.
  Publicat: (2018)